GDC-046 is a potent, selective, and orally bioavailable TYK2 inhibitor for TYK2, JAK1, JAK2, and JAK3, respectively.
For research use only. We do not sell to patients.
Name | GDC-046 |
---|---|
Iupac Chemical Name | 2,6-dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide |
Synonyms | GDC-046; GDC 046; GDC046 |
Molecular Formula | C16H13Cl2N3O2 |
Molecular Weight | 350.20 |
Smile | O=C(NC1=CC(NC(C2CC2)=O)=NC=C1)C3=C(Cl)C=CC=C3Cl |
InChiKey | IAFNAEGXTKTGHN-UHFFFAOYSA-N |
InChi | InChI=1S/C16H13Cl2N3O2/c17-11-2-1-3-12(18)14(11)16(23)20-10-6-7-19-13(8-10)21-15(22)9-4-5-9/h1-3,6-9H,4-5H2,(H2,19,20,21,22,23) |
CAS Number | 1258292-64-6 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% Min. |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |
1: Liang J, van Abbema A, Balazs M, et al. Lead optimization of a 4-aminopyridine benzamide scaffold to identify potent, selective, and orally bioavailable TYK2 inhibitors. J Med Chem. 2013;56(11):4521-4536. doi:10.1021/jm400266t